|
International prognostic index (IPI) for aggressive NHL | |
|
Risk factors |
Cutoff value |
|
Age |
≤60 years vs >60 years |
|
ECOG performance status (see ecog-acrin.org) |
<2 vs ≥2 |
|
Clinical stage (see table 9.3-3) |
I/II vs III/IV |
|
Number of extranodal sites involved |
≤1 vs >1 |
|
Serum LDH level |
≤ULN vs >ULN |
|
Risk groups |
Number of risk factors |
|
Low risk |
≤1 |
|
Low-intermediate risk |
2 |
|
High-intermediate risk |
3 |
|
High risk |
≥4 |
|
Follicular lymphoma-specific international prognostic index (FLIPI) for indolent NHL | |
|
Risk factors |
Cutoff value |
|
Age |
≤60 years vs >60 years |
|
Number of extranodal sites involved |
≤4 vs >4 |
|
Clinical stage (see table 9.3-3) |
I/II vs III/IV |
|
Hemoglobin level |
<12 g/dL vs ≥12 g/dL |
|
Serum LDH level |
≤ULN vs >ULN |
|
Risk groups |
Number of risk factors |
|
Low risk |
≤1 |
|
Intermediate risk |
2-3 |
|
High risk |
4-5 |
|
ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; NHL, non-Hodgkin lymphoma; ULN, upper limit of normal. | |